Literature DB >> 16323968

Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.

Ibtisam Al-Hashimi1.   

Abstract

Xerostomia is a common symptom in the elderly population. Studies have suggested that the underlying cause of approximately 40% of xerostomia in the elderly is Sjögren's syndrome. Although it is highly prevalent among middle-aged individuals, elderly patients account for up to 20% of Sjögren's syndrome cases. Sjögren's syndrome is a multisystem exocrinopathy characterised by dry mouth and dry eyes with wide-ranging extraglandular involvement. The exocrine manifestations of Sjögren's syndrome affect the mouth, eyes, nose, ears, skin, vagina and the entire respiratory and gastrointestinal systems. The nonexocrine involvement may include the joints, thyroid gland, liver, kidneys and the musculoskeletal, vascular and central nervous systems. Currently, the mechanism(s) of development and progression of Sjögren's syndrome is/are not clear. Inflammation and lymphocytic infiltration of the exocrine glands is a classical feature of Sjögren's syndrome. During the progression of the disease, the acinar cells of the exocrine glands are replaced by fibrosis, rendering the glands nonfunctional. Sjögren's syndrome remains one of the most underdiagnosed conditions, particularly in the elderly population, because the cardinal sicca symptoms, which are the hallmark of the disease, are frequently attributed to aging and/or medications, which consequently delays the diagnosis. This delay in diagnosis imposes significant physical, psychological and economic burdens on elderly patients. The diagnosis of Sjögren's syndrome requires evaluation of both the exocrine and nonexocrine components of the disease. Management of Sjögren's syndrome requires collaboration by the primary-care physician, rheumatologist, ophthalmologist and dentist. This article reviews current understanding of the clinical manifestations, diagnosis and treatment of Sjögren's syndrome with special emphasis on the oral component of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16323968     DOI: 10.2165/00002512-200522110-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  88 in total

1.  Effect of xerostomic medications on stimulated salivary flow rate in patients with Sjögren's syndrome.

Authors:  D D Simmons; I Al-Hashimi; N Haghighat
Journal:  Quintessence Int       Date:  2000-03       Impact factor: 1.677

2.  A comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls.

Authors:  S Taiym; N Haghighat; I Al-Hashimi
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2004-05

3.  Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements.

Authors:  M Yamazaki; R Kitamura; S Kusano; H Eda; S Sato; M Okawa-Takatsuji; S Aotsuka; K Yanagi
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

Review 4.  Salivary gland function during aging.

Authors:  B J Baum
Journal:  Gerodontics       Date:  1986-04

5.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

Review 6.  Classification and differential diagnosis of sialographic characteristics in Sjögren syndrome.

Authors:  P F Dijkstra
Journal:  Semin Arthritis Rheum       Date:  1980-08       Impact factor: 5.532

Review 7.  Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome.

Authors:  W A van der Reijden; A Vissink; E C Veerman; A V Amerongen
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

8.  The occurrence of xerostomia and salivary gland hypofunction in a population-based sample of older South Australians.

Authors:  W M Thomson; J M Chalmers; A J Spencer; M Ketabi
Journal:  Spec Care Dentist       Date:  1999 Jan-Feb

9.  Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.

Authors:  Ann Rose Hammi; Ibtisam H Al-Hashimi; Martha E Nunn; Michele Zipp
Journal:  J Oral Pathol Med       Date:  2005-04       Impact factor: 4.253

10.  True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.

Authors:  Salvatore De Vita; Rosaria Damato; Ginevra De Marchi; Stefania Sacco; Gianfranco Ferraccioli
Journal:  Isr Med Assoc J       Date:  2002-12       Impact factor: 0.892

View more
  12 in total

Review 1.  Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment.

Authors:  Deana Lazaro
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 2.  The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.

Authors:  Ying Sun; Weici Zhang; Baosen Li; Zhengsheng Zou; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

3.  [Sjögren's syndrome. Current aspects from a rheumatological point of view].

Authors:  C Tomiak; T Dörner
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

Review 4.  Sjögren's syndrome in older patients: aetiology, diagnosis and management.

Authors:  Rada V Moerman; Hendrika Bootsma; Frans G M Kroese; Arjan Vissink
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923

5.  Cevimeline.

Authors:  Juliane Weber; Gillian M Keating
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 6.  Sjögren's syndrome: diagnosis and therapeutic challenges in the elderly.

Authors:  Kristine P Ng; David A Isenberg
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

7.  Frequency and risk factors associated with dry eye in patients attending a tertiary care ophthalmology center in Mexico City.

Authors:  Jaime D Martinez; Anat Galor; Nallely Ramos-Betancourt; Andrés Lisker-Cervantes; Francisco Beltrán; Jorge Ozorno-Zárate; Valeria Sánchez-Huerta; Marco-Antonio Torres-Vera; Everardo Hernández-Quintela
Journal:  Clin Ophthalmol       Date:  2016-07-21

8.  Next Generation Salivary Lubrication Enhancer Derived from Recombinant Supercharged Polypeptides for Xerostomia.

Authors:  Hongping Wan; Chao Ma; Jeroen Vinke; Arjan Vissink; Andreas Herrmann; Prashant K Sharma
Journal:  ACS Appl Mater Interfaces       Date:  2020-07-21       Impact factor: 9.229

9.  The lived experience of Sjögren's Syndrome.

Authors:  Di Ying J Ngo; William M Thomson; Anita Nolan; Shelagh Ferguson
Journal:  BMC Oral Health       Date:  2016-02-01       Impact factor: 2.757

10.  An ex vivo salivary lubrication system to mimic xerostomic conditions and to predict the lubricating properties of xerostomia relieving agents.

Authors:  Jeroen Vinke; Hans J Kaper; Arjan Vissink; Prashant K Sharma
Journal:  Sci Rep       Date:  2018-06-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.